Moreover, the effects of PPARβ/δ on NAFLD, including its capacity to decrease lipogenesis, improve inflammation and endoplasmic reticulum stress, alleviate insulin resistance, and attenuate liver injury [174]. The gene discussed is PPARD; the disease is metabolic dysfunction-associated steatotic liver disease.